Angela (Yumin) Li, Senior Vice President, Regulatory Affairs,Beijing Clinical Service Center
• 30 years of Regulatory Affairs experience in the pharmaceutical industry;
• Contributed herself to Merck Serono, Sanofi, and Bayer, etc. with rich experiences in CTA/NDA submission for innovative drugs;
• Major therapeutic areas of innovative products for CTA/NDA submission are Oncology, Immunology, and OTC, etc.;
• Successfully lead TAs of oncology and internal medicine (osteoporosis, diabetes, digest, external use, antibiotics. etc) for several Import Drug License applications and approvals;
• Keep well-communication with NMPA/CDE, and relevant IDCs, established a good professional relationship with relevant stakeholders.
